Topic neurodegenerative disorders

News neurodegenerative disorders

• BGU researchers make scientific breakthrough in the fight against neurodegenerative diseases

  A patented breakthrough treatment for neurodegenerative diseases has secured over $1 million. Prof. Esther Priel of Ben-Gurion University and her colleagues Prof. Aviv Gazit (formerly of Hebrew University) and Prof. Shimon Slavin (also formerly of Hebrew University and now director of the Internatio more

• ADx NeuroSciences NV enters into exclusive license agreement with K.U.Leuven for the development of antibodies used in dementia diagnosis

  ADx NeuroSciences NV entered into a license agreement with K.U.Leuven, the academic founder of ADx NeuroSciences. The license agreement grants ADx NeuroSciences exclusive worldwide rights to further develop and commercialise certain antibodies which selectively bind phosphorylated Tau aggregates. AD more

• Major ALS breakthrough

  The underlying disease process of amyotrophic lateral sclerosis (ALS and Lou Gehrig's disease), a fatal neurodegenerative disease that paralyzes its victims, has long eluded scientists and prevented development of effective therapies. Scientists weren't even sure all its forms actually converged int more

Publications neurodegenerative disorders

• Proteomic study of amyloid beta (25–35) peptide exposure to neuronal cells: Impact on APE1/Ref‐1's protein–protein interaction

  Abstract The genotoxic, extracellular accumulation of amyloid β (Aβ) protein and subsequent neuronal cell death are associated with Alzheimer's disease (AD). APE1/Ref‐1, the predominant apurinic/apyrimidinic (AP) endonuclease and essential in eukaryotic cells, plays a central role in the base exc more

• Genome-wide association study identifies novel loci associated with serum level of vitamin B12 in Chinese men

  Vitamin B12 (VitB12 or cobalamin) is an essential cofactor in several metabolic pathways. Clinically, VitB12 deficiency is associated with pernicious anemia, neurodegenerative disorder, cardiovascular disease and gastrointestinal disease. Although previous genome-wide association studies (GWAS) ide more

• The blood-brain barrier is disrupted in a mouse model of infantile neuronal ceroid lipofuscinosis: amelioration by resveratrol

  Disruption of the blood-brain barrier (BBB) is a serious complication frequently encountered in neurodegenerative disorders. Infantile neuronal ceroid lipofuscinosis (INCL) is a devastating childhood neurodegenerative lysosomal storage disorder caused by palmitoyl-protein thioesterase-1 (PPT1) defi more

Market studies neurodegenerative disorders

• Genfit (ALGFT) - Financial and Strategic SWOT Analysis Review

  Genfit (Genfit) is a publicly held biopharmaceutical company specialized in developing medicines for the early prevention and treatment of cardiometabolic diseases and related disorders. The company has its research work concentrated on the discovery and development of new treatments for the growing more

• Rexahn Pharmaceuticals, Inc. (RNN) - Financial and Strategic SWOT Analysis Review

  Rexahn Pharmaceuticals, Inc., (Rexahn Pharmaceuticals) is a biopharmaceutical company that is engaged in the discovery, manufacture and development of treatments for central nervous system (CNS) disorders, cancer and sexual dysfunction. It has developed three clinical stage drug candidates namely Se more

• Proximagen Group plc (PRX) - Financial and Strategic SWOT Analysis Review

  Proximagen Group plc, formerly known as Proximagen Neuroscience plc, is a publicly traded neuroscience research company, engaged in developing drugs for the treatment of neurodegenerative disorders. It principally focuses on parkinson's disease, epilepsy, gognition, oncology, inflammation and neuroi more

Websites neurodegenerative disorders